It was not poorly worded statement as I thought. It is spot on. They are and have had partnership discussion around cantrixil as the ASX ann clearly states. Nothing is for sure, but is show they are doing the leg work and the discussion are at least taking place as stated.
"We will be presenting data at the ESMO conference at the end of September, and this will be valuable opportunity to move forward our partnering discussions for Cantrixil.”
The question one must ask consider disclousre rules that clearly state that you do not have to disclosure this type of information above is why do it at all then.
It is just to lift hope a bit,.... a little bit of hype, a little bit speculation.
You be the judge considering the last three years of ann.
It was not poorly worded statement as I thought. It is spot on....
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)